PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, University of Huddersfield, Huddersfield, HD1 3DH, UK. s.hasan@hud.ac.uk.\', \'School of Postgraduate Studies, International Medical University, Kuala Lumpur, 57000, Malaysia.\', \'Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.\', \'School of Healthcare, University of Leeds, Leeds, LS2 9JT, UK.\', \'Leeds Teaching Hospitals NHS Trust, Leeds, LS2 9JT, UK.\', \'Department of Pharmacy, University of Huddersfield, Huddersfield, HD1 3DH, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40256-020-00439-5
?:doi
?:hasPublicationType
?:journal
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
is ?:pmid of
?:pmid
?:pmid
  • 32918209
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all